Login / Signup

New anti-tuberculosis drugs for special populations: a difficult-to-address issue.

Giovanni SotgiuEmanuele PontaliRosella CentisLia D'AmbrosioGiovanni Battista Migliori
Published in: The European respiratory journal (2018)
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • genetic diversity
  • adverse drug
  • emergency department
  • drug induced
  • human immunodeficiency virus